GlassScriptPhysician profile
Joe H Morgan
NPI 1427230150
$6,098.47
in general payments reported to CMS, 2019-2025
32 companies · $501 in 2025
The $501 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $759 · 2020: $272 · 2021: $369 · 2022: $884 · 2023: $926 · 2024: $2,388 · 2025: $501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,319 · Travel and Lodging: $1,480 · Education: $16.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,318.98 |
| Travel and Lodging | $1,479.75 |
| Education | $16.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $1,825.83 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Bard Peripheral Vascular, INC. | $946.65 | 2019-2025 | Rotarexs 6 F X 135 Cm, Venclose Maven Catheter, Venovo |
| Cardiovascular Systems INC. | $499.94 | 2019-2023 | Diamondback Peripheral |
| Organogenesis INC. | $352.43 | 2019-2023 | Puraply |
| Boston Scientific Corporation | $292.59 | 2023-2025 | General - Balloons, Varithena Administration Pack, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Vanda Pharmaceuticals INC. | $254.54 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $251.81 | 2022-2024 | Caplyta |
| Janssen Pharmaceuticals, INC | $228.89 | 2020-2024 | Xarelto |
| Inari Medical, INC. | $225.94 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Endologix LLC | $217.31 | 2019 | |
| Abbott Laboratories | $183.02 | 2023-2024 | Diamondback Peripheral, Esprit, Supera |
| Medtronic, INC. | $103.02 | 2022-2025 | Venaseal |
| Kerecis Limited | $100.41 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Smith+Nephew, INC. | $61.43 | 2024-2025 | Collagenase Santyl |
| Philips North America LLC | $55.02 | 2019-2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $52.15 | 2020-2021 | |
| Paratek Pharmaceuticals, INC. | $50.15 | 2023-2024 | Nuzyra |
| Supernus Pharmaceuticals, INC. | $47.41 | 2023 | Qelbree |
| Bioxcel Therapeutics, INC. | $42.63 | 2024 | Igalmi |
| Cordis US Corp. | $41.05 | 2021-2024 | S.M.A.R.T. |
| Ironshore Pharmaceuticals INC. | $37.57 | 2021-2024 | |
| Lemaitre Vascular, INC. | $36.74 | 2022-2024 | Artegraft Vascular Graft |
| Globus Medical, INC. | $32.40 | 2025 | Senza |
| Baxter Healthcare | $25.58 | 2023 | Renal - Pd |
| Angiodynamics, INC. | $22.09 | 2023 | Auryon Laser System 100-120 Vac |
| Stryker Corporation | $20.83 | 2025 | Artix Mt |
| Penumbra, INC. | $16.97 | 2024 | Indigo System |
| Neuros Medical, INC. | $15.56 | 2025 | Altius |
| Osiris Therapeutics INC. | $15.09 | 2019 | |
| W. L. Gore & Associates, INC. | $14.97 | 2022 | |
| Jazz Pharmaceuticals INC. | $14.34 | 2019 | |
| Cashflow Solutions, LLC | $14.11 | 2023 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joe Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.